Akamai Technologies Other Income (Expense) decreased by 35.3% to -$1.79M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 129.7%, from $6.02M to -$1.79M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a -24.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$811.00K | $3.64M | -$9.57M | $816.00K | -$275.00K | -$1.41M | -$2.36M | -$1.13M | -$3.16M | -$5.64M | $511.00K | -$949.00K | -$13.16M | -$5.96M | $6.02M | -$5.45M | -$3.84M | -$1.32M | -$1.79M |
| QoQ Change | — | +548.2% | -363.1% | +108.5% | -133.7% | -412.4% | -67.7% | +52.2% | -179.7% | -78.5% | +109.1% | -285.7% | <-999% | +54.7% | +201.0% | -190.5% | +29.6% | +65.6% | -35.3% |
| YoY Change | — | — | — | +200.6% | -107.6% | — | +75.3% | -238.5% | <-999% | -300.4% | +121.6% | +16.0% | -316.4% | -5.7% | >999% | -474.4% | +70.8% | +77.9% | -129.7% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $6.02M | -$5.45M | -$3.84M | $7.86M | -$1.79M |
| Total | $6.02M | -$5.45M | -$3.84M | -$1.32M | -$1.79M |